You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 124 No. 4, April 2006 TABLE OF CONTENTS
  Archives
  •  Online Features
  Laboratory Sciences
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (5)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Ocular Imaging
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Staining Ability and Biocompatibility of Brilliant Blue G

Preclinical Study of Brilliant Blue G as an Adjunct for Capsular Staining

Toshio Hisatomi, MD, PhD; Hiroshi Enaida, MD, PhD; Hiroyoshi Matsumoto, MD; Tadahisa Kagimoto, MD; Akifumi Ueno, MD; Yasuaki Hata, MD, PhD; Toshiaki Kubota, MD, PhD; Yoshinobu Goto, MD, PhD; Tatsuro Ishibashi, MD, PhD

Arch Ophthalmol. 2006;124:514-519.

Objective  To evaluate the effectiveness and biocompatibility of brilliant blue G (BBG) for capsular visualization for continuous curvilinear capsulorrhexis.

Methods  The capsular staining ability of BBG was evaluated at graded concentrations of 10.0, 1.0, 0.5, 0.25, 0.1, and 0.01 mg/mL in enucleated pig's eyes. The biocompatibility of BBG was assessed in rat's eyes for 2 months. The eyes were analyzed using light, fluorescence, transmission electron, and scanning electron microscopy. TUNEL (terminal deoxynucleotidyl transferase–mediated biotin–deoxyuridine triphosphate nick-end labeling) was used to detect apoptotic cells, and endothelial cell counts were analyzed using scanning electron microscopy. The results were compared using indocyanine green and trypan blue.

Results  The BBG improved capsular visualization, and a complete capsulorrhexis could be performed. In the rat model, no apparent toxic effect was observed using biomicroscopy during 2 months. Histologically, BBG showed satisfactory biocompatibility. Apoptotic cell death of the endothelial cells was detected in only the trypan blue group. In contrast to BBG, indocyanine green and trypan blue showed degeneration of corneal endothelial cells using transmission and scanning electron microscopy.

Conclusion  The BBG contributed to better capsular visualization and caused no apparent complications to the corneal endothelium.

Clinical Relevance  The BBG is effective and safe capsular staining for continuous curvilinear capsulorrhexis.


Author Affiliations: Departments of Ophthalmology (Drs Hisatomi, Enaida, Matsumoto, Kagimoto, Ueno, Hata, and Ishibashi) and Neurophysiology (Dr Goto), Graduate School of Medical Sciences, Kyushu University, and Department of Ophthalmology, University of Occupational and Environmental Health (Dr Kubota), Fukuoka, Japan.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Altered P2X7-receptor level and function in mouse models of Huntington's disease and therapeutic efficacy of antagonist administration
Diaz-Hernandez et al.
FASEB J. 2009;23:1893-1906.
ABSTRACT | FULL TEXT  

Intracellular Events in Retinal Glial Cells Exposed to ICG and BBG
Kawahara et al.
IOVS 2007;48:4426-4432.
ABSTRACT | FULL TEXT  

From the Library
Br J Ophthalmol 2006;90:930-930.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2006 American Medical Association. All Rights Reserved.